Cargando…

Synthesis and preclinical evaluation of novel (99m)Tc-labeled PSMA ligands for radioguided surgery of prostate cancer

BACKGROUND: Radioguided surgery (RGS) has recently emerged as a valuable new tool in the management of recurrent prostate cancer (PCa). After preoperative injection of a (99m)Tc-labeled prostate-specific membrane antigen (PSMA) inhibitor, radioguided intraoperative identification and resection of le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunert, Jan-Philip, Müller, Max, Günther, Thomas, Stopper, León, Urtz-Urban, Nicole, Beck, Roswitha, Wester, Hans-Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842843/ https://www.ncbi.nlm.nih.gov/pubmed/36645586 http://dx.doi.org/10.1186/s13550-022-00942-7

Ejemplares similares

Optimization of the Pharmacokinetic Profile of [(99m)Tc]Tc-N(4)-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
por: Günther, Thomas, et al.
Publicado: (2022)

Synthesis and Preclinical Evaluation of (177)Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
por: Wurzer, Alexander, et al.
Publicado: (2022)

Automated synthesis and quality control of [(99m)Tc]Tc-PSMA for radioguided surgery (in a [(68)Ga]Ga-PSMA workflow)
por: Aalbersberg, Else A., et al.
Publicado: (2020)

[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
por: Schottelius, Margret, et al.
Publicado: (2015)

Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensive (99m)Tc-labeling for SPECT imaging and radioguided surgery in prostate cancer
por: Fuscaldi, Leonardo Lima, et al.
Publicado: (2023)

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors
por: Wurzer, Alexander, et al.
Publicado: (2020)

[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020)

(99m)Tc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
por: Mix, Michael, et al.
Publicado: (2021)

Preclinical comparison of four [(18)F, (nat)Ga]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics
por: Wurzer, Alexander, et al.
Publicado: (2020)

PSAT218 Technetium 99m-Methyl Diphosphonate (99mTc MDP) Radioguided Surgery in Patient With Tumor-Induced Osteomalacia (TIO)
por: Khan, Sara A, et al.
Publicado: (2022)

High cardiac background activity limits (99m)Tc-MIBI radioguided surgery in aortopulmonary window parathyroid adenomas
por: Schwarzlmüller, Thomas, et al.
Publicado: (2014)

Comparing (99m)Tc-PSMA to (99m)Tc-MDP in Prostate Cancer Staging of the Skeletal System
por: Kabunda, Joseph, et al.
Publicado: (2021)

Development of in-House Synthesis and Quality Control of [(99m)Tc]Tc-PSMA-I&S
por: Plhak, Elisabeth, et al.
Publicado: (2023)

Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
por: Weineisen, Martina, et al.
Publicado: (2014)

Design and preclinical evaluation of a (99m)Tc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
por: Kampmeier, Florian, et al.
Publicado: (2014)

Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer
por: Schottelius, Margret, et al.
Publicado: (2019)

Development of the First (18)F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety
por: Günther, Thomas, et al.
Publicado: (2023)

[(99m)Tc]Tc-PSMA-T4—Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic
por: Maurin, Michał, et al.
Publicado: (2022)

Use of (99m)Tc 2-methoxyisobutyl isonitrile in minimally invasive radioguided surgery in patients with primary hyperparathyroidism: A narrative review of the current literature
por: Denmeade, Kristie A, et al.
Publicado: (2013)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007
por: Robu, Stephanie, et al.
Publicado: (2018)

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

A Preclinical Study of an (125)I-Labeled PSMA Ligand for Prostate-Cancer Puncture
por: Luan, Xiaohui, et al.
Publicado: (2022)

Effect of Carbohydration on the Theranostic Tracer PSMA I&T
por: Schmidt, Alexander, et al.
Publicado: (2018)

Preparation and Biological Evaluation of [(99m)Tc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer
por: Xiao, Di, et al.
Publicado: (2020)

A Review on the Current State and Future Perspectives of [(99m)Tc]Tc-Housed PSMA-i in Prostate Cancer
por: Brunello, Sara, et al.
Publicado: (2022)

[(18)F]PSMA-1007 PET is comparable to [(99m)Tc]Tc-DMSA SPECT for renal cortical imaging
por: Valind, Kristian, et al.
Publicado: (2023)

Preclinical Evaluation of a Novel (99m)Tc-Labeled CB86 for Rheumatoid Arthritis Imaging
por: Liu, Peng, et al.
Publicado: (2020)

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
por: Peeken, Jan C., et al.
Publicado: (2020)

Feasibility and long-term results of focused radioguided parathyroidectomy using a "low" 37 MBq (1 mCi) (99m)Tc-sestamibi protocol
por: Rubello, Domenico, et al.
Publicado: (2006)

Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control
por: Philadelpho Arantes Pereira, Fernanda, et al.
Publicado: (2013)

PSMA-GCK01: A Generator-Based (99m)Tc/(188)Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
por: Cardinale, Jens, et al.
Publicado: (2023)

Direct comparison of (99m)Tc-PSMA SPECT/CT and (68)Ga-PSMA PET/CT in patients with prostate cancer
por: Albalooshi, Batool, et al.
Publicado: (2020)

Evaluation of (99m)Tc-labeled PSMA-SPECT/CT imaging in prostate cancer patients who have undergone biochemical relapse
por: Su, Heng-Chuan, et al.
Publicado: (2017)

Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
por: Felber, Veronika Barbara, et al.
Publicado: (2021)

Comparison of [(99m)Tc]Tc-tilmanocept with [(99m)Tc]Tc-sulphur colloids and [(99m)Tc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head
por: Ooms, Mark, et al.
Publicado: (2022)

Initial Experience of Clinical Use of [(99m)Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
por: Ćwikła, Jarosław B., et al.
Publicado: (2021)

Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010)

Biodistribution of (99m)Tc Labeled Integrin Antagonist
por: Jang, Beom-Su, et al.
Publicado: (2013)

(99m)Tc-besilesomab (Scintimun®) in peripheral osteomyelitis: comparison with (99m)Tc-labelled white blood cells
por: Richter, Wolf S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1t6v6v3vm4qjpl3sgeckv7413v